ADXN
Addex Therapeutics Ltd
NASDAQ: ADXN · HEALTHCARE · BIOTECHNOLOGY
$7.00
+3.86% today
Updated 2026-04-29
Market cap
$8.62M
P/E ratio
—
P/S ratio
54.40x
EPS (TTM)
$-9.17
Dividend yield
—
52W range
$5 – $12
Volume
0.0M
WallStSmart proprietary scores
20
out of 100
Grade: F
Strong Sell
Investment rating
2.7
Growth
F6.0
Quality
B2.5
Profitability
F5.0
Valuation
C+3/9
Piotroski F-Score
Weak
-41.7
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$30.00
+328.57%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
Price chart
X-Ray snapshot
Strengths
+ Debt/equity 0.01x — low leverage
Risks
- Piotroski 3/9 — weak financial health
- Altman Z -41.70 — distress zone
- Thin margins at 0.00%
- Negative free cash flow $-533203.00
- Revenue declining -15.00% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|
| Revenue | $2.92M | $1.42M | $1.61M | $404102.00 | $158540.00 |
| Net income | $-15.35M | $-20.80M | $-10.56M | $7.06M | $-1.58M |
| EPS | — | — | — | — | $-9.17 |
| Free cash flow | $-14.74M | $-16.44M | $-8.00M | $-5.37M | $-533203.00 |
| Profit margin | -526.42% | -1,462.57% | -654.47% | 1,746.04% | — |
Peer comparison
Smart narrative
Addex Therapeutics Ltd trades at $7.00. Our Smart Value Score of 20/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of -41.70, it sits in the distress. TTM revenue stands at $158540.00.
Frequently asked questions
What is Addex Therapeutics Ltd's stock price?
Addex Therapeutics Ltd (ADXN) trades at $7.00.
Is Addex Therapeutics Ltd overvalued?
Smart Value Score 20/100 (Grade F, Strong Sell).
What is the price target of Addex Therapeutics Ltd (ADXN)?
The analyst target price is $30.00, representing +328.6% upside from the current price of $7.00.
What is Addex Therapeutics Ltd's revenue?
TTM revenue is $158540.00.
Piotroski F-Score?
3/9 — weak financial health.
Altman Z-Score?
-41.70 — distress.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio54.40x
ROE-72.80%
Beta1.87
50D MA$6.77
200D MA$7.99
Shares out0.00B
Float0.09B
Short ratio—
Avg volume0.0M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—